Transcept Pharmaceuticals to Report Third Quarter 2012 Financial Results and Host Conference Call on November 12, 2012
POINT RICHMOND, Calif., Nov. 6, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on Monday, November 12, 2012, at 4:30 p.m. Eastern Time to discuss its third quarter 2012 financial results. The conference call will follow the release of the Transcept third quarter 2012 financial results after the close of market that day.
|
Conference Call Information |
|
|
Date: Monday, November 12, 2012 | |
|
Time: 4:30 p.m. ET | |
|
Dial-in (U.S.): 877-638-4558 | |
|
Dial-in (International): 914-495-8537 |
A simultaneous webcast of the conference call will be available on the Investors section of the Transcept website at www.transcept.com. A replay of this webcast will be available on the website shortly after the conclusion of the call through January 30, 2013.
About Transcept
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Intermezzo® (zolpidem tartrate) sublingual tablet C-IV is the first FDA approved Transcept product. Purdue Pharma holds commercialization and development rights for Intermezzo in the United States. Transcept is currently conducting a Phase 2 study of an investigational product, TO-2061, in patients with obsessive-compulsive disorder. For further information about Transcept, please visit www.transcept.com. For information about Intermezzo, please visit www.IntermezzoRx.com.
Contact:
Transcept Pharmaceuticals, Inc.
Greg Mann
Sr. Director, Corporate Communications
(510) 215-3567
gmann@transcept.com
SOURCE Transcept Pharmaceuticals, Inc.
RELATED LINKS
http://www.transcept.com
More by this Source
Transcept Pharmaceuticals Reports First Quarter 2013 Financial Results
May 08, 2013, 13:25 ET
Transcept Pharmaceuticals to Report First Quarter 2013 Financial Results and Host Conference Call on May 8, 2013
May 01, 2013, 16:15 ET
Thomas J. Dietz, Ph.D., Appointed To The Transcept Pharmaceuticals Board Of Directors
Apr 10, 2013, 17:59 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.